CPHA Canvax

The National Advisory Committee on Immunization (NACI) strongly recommends that, among other high-risk groups, adults aged 65 years and older be vaccinated against influenza and pneumococcal disease. Yet, vaccination coverage rates remain low. The Canadian Longitudinal Study on Aging (CLSA) offers a unique opportunity to investigate the relationship between vaccine uptake and a wide range of sociodemographic, clinical, and behavioural factors among Canadian adults — particularly among older age groups. In this webinar, Dr. Giorgia Sulis shares her insights on the use of CLSA data to identify vaccine coverage gaps in older adults and inform policies that improve vaccine uptake in this demographic.

Rating See Comments Ratings


Vaccination Decision Making,Vaccine Acceptance and Uptake,Understanding Vaccine Acceptance and Uptake,Vaccine Preventable Diseases,Communicable Diseases,Influenza,Pneumococcal Disease,Specific Populations,Seniors,High Risk Adults Vaccination Decision Making
Vaccine Acceptance and Uptake
Understanding Vaccine Acceptance and Uptake
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations
High Risk Adults


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.